Evidence map›Paper›PMID 32899657›Full record

ReviewViruses2020

Advances in Continuous Microfluidics-Based Technologies for the Study of HIV Infection.

Joëlle Eid, Marylène Mougel, Marius Socol

Abstract readReview
In one paragraph

Review in Viruses, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Joëlle EidInstitute of Research in Infectious Diseases (IRIM), Centre National de la Recherche Scientifique (CNRS), UMR9004, University of Montpellier, Team R2D2, 34293 Montpellier, France.
Marylène MougelInstitute of Research in Infectious Diseases (IRIM), Centre National de la Recherche Scientifique (CNRS), UMR9004, University of Montpellier, Team R2D2, 34293 Montpellier, France.ORCID 0000-0002-0345-1427
Marius SocolInstitute of Research in Infectious Diseases (IRIM), Centre National de la Recherche Scientifique (CNRS), UMR9004, University of Montpellier, Team R2D2, 34293 Montpellier, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HIV-1 is the causative agent of acquired immunodeficiency syndrome (AIDS). It affects millions of people worldwide and the pandemic persists despite the implementation of highly active antiretroviral therapy. A wide spectrum of techniques has been implemented in order to diagnose and monitor AIDS progression over the years. Besides the conventional approaches, microfluidics has provided useful methods for monitoring HIV-1 infection. In this review, we introduce continuous microfluidics as well as the fabrication and handling of microfluidic chips. We provide a review of the different applications of continuous microfluidics in AIDS diagnosis and progression and in the basic study of the HIV-1 life cycle.

Indexed as

Microfluidic Analytical TechniquesMicrofluidicsAcquired Immunodeficiency SyndromeDisease ProgressionHIV-1HIV InfectionsHumansVirus ReplicationdiagnosisHIVinfectionlife cyclemicrofluidicsreplicationretrovirus

Identifiers

PMID32899657
PMCPMC7552050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.